Members

UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, focusing on innovative treatments for severe diseases in immunology and neurology.

Université catholique de Louvain (UCLouvain), Belgium's largest French-speaking university, offers diverse programs across multiple campuses, emphasizing research excellence and humanistic values since 1834.

The University of Liège (ULiège), founded in 1817, is a public university in Belgium offering diverse programs across 11 faculties, emphasizing research and education.

Unisensor, founded in 1997, specialises in developing and manufacturing in vitro diagnostic kits for both human and animal health.

Univercells Group develops innovative biomanufacturing platforms to make biologics, including vaccines and therapies, more accessible and affordable globally.

Established in 2009, the University of Mons provides multidisciplinary education and excels in research, following the merger of two historic institutions.

Founded in 1831, the University of Namur offers diverse programs, emphasizing academic excellence, research, and social responsibility.

Université Libre de Bruxelles (ULB), a French-speaking research university in Brussels, offers diverse programs and upholds democratic and humanistic values since its founding in 1834.

Vésale Pharma develops innovative probiotic solutions for digestive, pediatric, immune, and women's health, using patented Intelicaps® micro-encapsulation technology to enhance probiotic stability and effectiveness.

VILS designs and builds development and production facilities for cell and gene therapies and cellular agriculture, enabling rapid transition from lab to market.

Voxdale, established in 2007, delivers multidisciplinary engineering and design solutions, specializing in medtech and hardware innovation to drive impactful and sustainable technological advancements.

Specialists in small batches, helping biotech companies to fill their products faster with more flexibility

Ziphius Vaccines is a biotechnology company focused on the development of self-amplifying RNA-based (saRNA) vaccines and therapeutics.